CA
BNGO icon

Cetera Advisors’s Bionano Genomics BNGO Stock Holding History

Cetera Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$163K Buy
+2,447
New +$183K ﹤0.01% 2257
2023
Q3 		– Sell
-20
Closed -$7.23K – 1719
2023
Q2 		$7.23K Buy
+20
New +$9.03K ﹤0.01% 1650

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Cetera Advisors's BNGO Position: Q1 2024 in Review

Cetera Advisors opened a new position in Bionano Genomics (BNGO) in Q1 2024: 2,447 shares worth $163K. The stake represents ﹤0.01% of the portfolio and ranks #2257 among its holdings. This is a return to the name: Cetera Advisors previously reported a position in BNGO as recently as Q2 2023.

Cetera Advisors first reported a position in BNGO in Q2 2023 and has held it in 2 quarters since. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

  • Cetera Advisors held 2,447 shares of Bionano Genomics worth $163K as of Q1 2024.
  • Bionano Genomics was a new Cetera Advisors position in Q1 2024.
  • Bionano Genomics made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2257 holding.
  • Cetera Advisors first reported a position in Bionano Genomics in Q2 2023 and has held it in 2 quarters since.
  • 55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.